AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Company Reports - CBNB)
Mylan Laboratories Inc (Mylan) announced its financial results for 3Q and nine months ended Dec 2005. The company reported adjusted earnings/diluted share for 3Q 2005-2006 of $0.25 and GAAP earnings/diluted share of $0.22. For nine months of 2005-2006, the company reported adjusted earnings/diluted share of $0.72 and GAAP earnings/diluted share of $0.53. Mylan also updated its adjusted diluted EPS guidance for the year ending Mar 2006 to $0.94 to $1, and its GAAP diluted EPS guidance to $0.75 to $0.81. With respect to 2006-2007 guidance, Mylan provided an updated range of $1.2 to $1.4/diluted share. Revenue …